Detalles de la búsqueda
1.
Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian community.
J Viral Hepat
; 31(6): 293-299, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436098
2.
Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (helping end addiction long-term®) communities study.
Prev Med
; 185: 108034, 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38857770
3.
Alternatives to dental opioid prescribing after tooth extraction (ADOPT): protocol for a stepped wedge cluster randomized trial.
BMC Oral Health
; 24(1): 414, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38575929
4.
Cannabinoid Poisoning-Related Emergency Department Visits and Inpatient Hospitalizations in Kentucky, 2017 to 2019.
Subst Use Misuse
; 58(1): 66-76, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453437
5.
Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections.
Clin Infect Dis
; 70(6): 1226-1229, 2020 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31342057
6.
Longitudinal trends in nonmedical prescription opioid use in a cohort of rural Appalachian people who use drugs.
Prev Med
; 140: 106194, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32652132
7.
A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
Addict Biol
; 25(4): e12799, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240842
8.
Deploying science to change hearts and minds: Responding to the opioid crisis.
Prev Med
; 128: 105780, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319116
9.
Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model.
Prev Med
; 128: 105760, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31251946
10.
Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment.
Curr HIV/AIDS Rep
; 15(4): 315-323, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29948609
11.
A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials.
J Clin Psychopharmacol
; 36(4): 324-32, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27300254
12.
Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans.
Addict Biol
; 21(1): 146-58, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25130052
13.
Distribution of naloxone for overdose prevention to chronic pain patients.
Prev Med
; 80: 41-3, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26024850
14.
Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021.
Drug Alcohol Depend
; 255: 111062, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38157702
15.
Get It in Writing: How to Make Medications for Opioid Use Disorder Available During Incarceration.
J Correct Health Care
; 30(1): 3-6, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38150232
16.
Drug disposal deserts: An assessment of receptacle availability in Kentucky community pharmacies.
J Rural Health
; 40(1): 208-214, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491595
17.
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder.
Neuropsychopharmacology
; 49(6): 1050-1057, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38200140
18.
Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.
J Subst Use Addict Treat
; : 209391, 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38740189
19.
Equity of overdose education and naloxone distribution provided in the Kentucky HEALing Communities Study.
Drug Alcohol Depend Rep
; 10: 100207, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38283913
20.
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality.
J Addict Med
; 18(3): 319-326, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598300